BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

779 related articles for article (PubMed ID: 27021323)

  • 1. Biofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species.
    Marcos-Zambrano LJ; Gómez-Perosanz M; Escribano P; Zaragoza O; Bouza E; Guinea J
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3579-86. PubMed ID: 27021323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the antifungal activity of micafungin and amphotericin B against Candida tropicalis biofilms.
    Marcos-Zambrano LJ; Escribano P; Bouza E; Guinea J
    J Antimicrob Chemother; 2016 Sep; 71(9):2498-501. PubMed ID: 27147303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of efficacy of echinocandins against high metabolic activity biofilms of Candida parapsilosis clinical isolates.
    Thomaz DY; Melhem MSC; de Almeida Júnior JN; Benard G; Del Negro GMB
    Braz J Microbiol; 2020 Sep; 51(3):1129-1133. PubMed ID: 31898245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical antifungal activity and structural observations in biofilms formed by echinocandin-resistant Candida albicans clinical isolates.
    Walraven CJ; Bernardo SM; Wiederhold NP; Lee SA
    Med Mycol; 2014 Feb; 52(2):131-139. PubMed ID: 24576999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of Candida albicans biofilms to caspofungin and anidulafungin is not affected by metabolic activity or biomass production.
    Marcos-Zambrano LJ; Escribano P; Bouza E; Guinea J
    Med Mycol; 2016 Feb; 54(2):155-61. PubMed ID: 26543157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS).
    Kritikos A; Neofytos D; Khanna N; Schreiber PW; Boggian K; Bille J; Schrenzel J; Mühlethaler K; Zbinden R; Bruderer T; Goldenberger D; Pfyffer G; Conen A; Van Delden C; Zimmerli S; Sanglard D; Bachmann D; Marchetti O; Lamoth F;
    Clin Microbiol Infect; 2018 Nov; 24(11):1214.e1-1214.e4. PubMed ID: 29909005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspofungin at catheter lock concentrations eradicates mature biofilms of Candida lusitaniae and Candida guilliermondii.
    Simitsopoulou M; Kyrpitzi D; Velegraki A; Walsh TJ; Roilides E
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4953-6. PubMed ID: 24890585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activities of nine antifungal agents against Candida auris biofilms.
    Chatzimoschou A; Giampani A; Meis JF; Roilides E
    Mycoses; 2021 Apr; 64(4):381-384. PubMed ID: 33270284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential in vivo activities of anidulafungin, caspofungin, and micafungin against Candida glabrata isolates with and without FKS resistance mutations.
    Arendrup MC; Perlin DS; Jensen RH; Howard SJ; Goodwin J; Hope W
    Antimicrob Agents Chemother; 2012 May; 56(5):2435-42. PubMed ID: 22354305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Echinocandins in Combination with Nikkomycin Z against Invasive Candida albicans Bloodstream Isolates and the
    Cheung YY; Hui M
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28827418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biofilm production and antifungal susceptibility patterns of Candida species isolated from hospitalized patients].
    Demirbileki M; Timurkaynak F; Can F; Azap O; Arslan H
    Mikrobiyol Bul; 2007 Apr; 41(2):261-9. PubMed ID: 17682713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echinocandin Resistance in Candida.
    Perlin DS
    Clin Infect Dis; 2015 Dec; 61 Suppl 6(Suppl 6):S612-7. PubMed ID: 26567278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of caspofungin susceptibility testing by the new Vitek 2 AST-YS06 yeast card using a unique collection of FKS wild-type and hot spot mutant isolates, including the five most common candida species.
    Astvad KM; Perlin DS; Johansen HK; Jensen RH; Arendrup MC
    Antimicrob Agents Chemother; 2013 Jan; 57(1):177-82. PubMed ID: 23089746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.
    Kordalewska M; Lee A; Park S; Berrio I; Chowdhary A; Zhao Y; Perlin DS
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632013
    [No Abstract]   [Full Text] [Related]  

  • 16. Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method.
    Espinel-Ingroff A; Arendrup M; Cantón E; Cordoba S; Dannaoui E; García-Rodríguez J; Gonzalez GM; Govender NP; Martin-Mazuelos E; Lackner M; Lass-Flörl C; Linares Sicilia MJ; Rodriguez-Iglesias MA; Pelaez T; Shields RK; Garcia-Effron G; Guinea J; Sanguinetti M; Turnidge J
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of micafungin against biofilms of Candida albicans, Candida glabrata, and Candida parapsilosis at different stages of maturation.
    Prażyńska M; Bogiel T; Gospodarek-Komkowska E
    Folia Microbiol (Praha); 2018 Mar; 63(2):209-216. PubMed ID: 28983822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.
    Alexander BD; Johnson MD; Pfeiffer CD; Jiménez-Ortigosa C; Catania J; Booker R; Castanheira M; Messer SA; Perlin DS; Pfaller MA
    Clin Infect Dis; 2013 Jun; 56(12):1724-32. PubMed ID: 23487382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches.
    Beyda ND; Lewis RE; Garey KW
    Ann Pharmacother; 2012; 46(7-8):1086-96. PubMed ID: 22811350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anidulafungin and micafungin MIC breakpoints are superior to that of caspofungin for identifying FKS mutant Candida glabrata strains and Echinocandin resistance.
    Shields RK; Nguyen MH; Press EG; Updike CL; Clancy CJ
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6361-5. PubMed ID: 24060873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.